{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:21:10Z","timestamp":1792574470418,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To evaluate the safety and efficacy of prostatic artery embolization (PAE) using polyethylene glycol microspheres (PEGM) in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>This multicentric prospective study enrolled 81 patients who underwent PAE with 400\u2009\u00b1\u200975\u00a0\u00b5m PEGM (HydroPearl\u00ae, Terumo, Japan). Results from baseline and 1-, 3-, 6-, and 12-month follow-ups were assessed for subjective outcomes including International Prostate Symptoms Score (IPSS), Quality of life (QoL), and International Index of Erectile Function, and objective outcomes such as peak urinary flow (Qmax) and post-void residual volume (PVR). The visual analogue scale, satisfaction questionnaire, prostatic volume, and prostatic specific antigen levels were also evaluated. Complications were documented using the modified Clavien\u2013Dindo classification.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Technical success was obtained in all patients. Clinical success was achieved in 78.5% of patients. Before PAE, 54.3% of patients had an indwelling catheter which was removed in 75% of them after procedure. A statistically significant decrease was observed in IPSS and QoL from baseline to 12\u00a0months (20.14 vs 5.89; 4.8 vs 0.63, <jats:italic>P<\/jats:italic>\u2009&lt;\u2009.01), respectively. Objective outcomes also showed a statistically significant improvement in Qmax (+\u2009114.9%; <jats:italic>P<\/jats:italic>\u2009&lt;\u2009.01), achieving a maximum urinary flow of 14.2\u00a0mL\/sec, and PVR (decrease 58%; <jats:italic>P<\/jats:italic>\u2009&lt;\u2009.05) at 12\u00a0months. Minor complications (Clavien\u2013Dindo grades I\u2013II) occurred in 13.6% of patients, without major complications observed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>PAE with PEGM is safe and effective treatment in patients with symptomatic BPH, with a significant improvement in both subjective and objective outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00270-022-03165-4","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T21:02:48Z","timestamp":1654203768000},"page":"1339-1348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prostatic Artery Embolization (PAE) Using Polyethylene Glycol Microspheres: Safety and Efficacy in 81 Patients"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7820-6469","authenticated-orcid":false,"given":"I\u00f1igo","family":"Insausti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkaitz","family":"Galbete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Lucas-Cava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana S\u00e1ez","family":"de Oc\u00e1riz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saioa","family":"Solchaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Monreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Mart\u00ednez","family":"de la Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Alfaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Montesino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fermin","family":"Urtasun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"Bilbao Jauregu\u00edzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"issue":"11","key":"3165_CR1","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.jvir.2016.08.004","volume":"27","author":"A Uflacker","year":"2016","unstructured":"Uflacker A, Haskal ZJ, Bilhim T, Patrie J, Huber T, Pisco JM. Meta-analysis of prostatic artery embolization for benign prostatic hyperplasia. J Vasc Interv Radiol. 2016;27(11):1686-1697.e8.","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"3165_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00270-020-02657-5","volume":"44","author":"GM Knight","year":"2021","unstructured":"Knight GM, Talwar A, Salem R, Mouli S. Systematic review and meta-analysis comparing prostatic artery embolization to gold-standard transurethral resection of the prostate for benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2021;44(2):183\u201393.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"7","key":"3165_CR3","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1007\/s00330-020-07663-2","volume":"31","author":"P Xiang","year":"2021","unstructured":"Xiang P, Guan D, Du Z, Hao Y, Yan W, Wang Y, et al. Efficacy and safety of prostatic artery embolization for benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials. Eur Radiol. 2021;31(7):4929\u201346.","journal-title":"Eur Radiol"},{"issue":"1","key":"3165_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1148\/radiol.2016152292","volume":"281","author":"T Bilhim","year":"2016","unstructured":"Bilhim T, Pisco J, Pereira JA, Costa NV, Fernandes L, Pinheiro LC, et al. Predictors of clinical outcome after prostate artery embolization with spherical and nonspherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia. Radiology. 2016;281(1):289\u2013300.","journal-title":"Radiology"},{"issue":"11","key":"3165_CR5","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.jvir.2013.06.003","volume":"24","author":"T Bilhim","year":"2013","unstructured":"Bilhim T, Pisco J, Campos Pinheiro L, Rio Tinto H, Fernandes L, Pereira JA, et al. Does polyvinyl alcohol particle size change the outcome of prostatic arterial embolization for benign prostatic hyperplasia? Results from a single-center randomized prospective study. J Vasc Interv Radiol. 2013;24(11):1595\u2013602.","journal-title":"J Vasc Interv Radiol"},{"issue":"12","key":"3165_CR6","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.jvir.2018.06.019","volume":"29","author":"MQ Wang","year":"2018","unstructured":"Wang MQ, Zhang JL, Xin HN, Yuan K, Yan J, Wang Y, et al. Comparison of clinical outcomes of prostatic artery embolization with 50-\u03bcm Plus 100-\u03bcm polyvinyl alcohol (PVA) particles versus 100-\u03bcm PVA particles alone: a prospective randomized trial. J Vasc Interv Radiol. 2018;29(12):1694\u2013702.","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"3165_CR7","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.jvir.2019.02.014","volume":"30","author":"D Torres","year":"2019","unstructured":"Torres D, Costa NV, Pisco J, Pinheiro LC, Oliveira AG, Bilhim T. Prostatic artery embolization for benign prostatic hyperplasia: prospective randomized trial of 100\u2013300 \u03bcm versus 300\u2013500 \u03bcm versus 100- to 300-\u03bcm + 300- to 500-\u03bcm embospheres. J Vasc Interv Radiol. 2019;30(5):638\u201344.","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"3165_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jvir.2018.10.009","volume":"30","author":"T Bilhim","year":"2019","unstructured":"Bilhim T. Endovascular resection of the prostate: how much is enough for prostate artery embolization? J Vasc Interv Radiol. 2019;30(2):225\u20137.","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"3165_CR9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jvir.2016.01.146","volume":"27","author":"AJ Isaacson","year":"2016","unstructured":"Isaacson AJ, Raynor MC, Yu H, Burke CT. Prostatic artery embolization using embosphere microspheres for prostates measuring 80\u2013150 cm(3): early results from a US trial. J Vasc Interv Radiol. 2016;27(5):709\u201314.","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"3165_CR10","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1007\/s00270-014-0908-z","volume":"37","author":"FC Carnevale","year":"2014","unstructured":"Carnevale FC, Moreira AM, Antunes AA. The \u201cPErFecTED technique\u201d: proximal embolization first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2014;37(6):1602\u20135.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3165_CR11","first-page":"40","volume":"19","author":"T Bilhim","year":"2020","unstructured":"Bilhim T. Prostatic artery embolization for benign prostatic hyperplasia: a 10-year update. Endovasc Today. 2020;19:40\u20134.","journal-title":"Endovasc Today"},{"issue":"1","key":"3165_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42155-021-00223-9","volume":"4","author":"MA Patetta","year":"2021","unstructured":"Patetta MA, Isaacson AJ, Stewart JK. Initial experience with hydropearl microspheres for uterine artery embolization for the treatment of symptomatic uterine fibroids. CVIR Endovasc. 2021;4(1):1\u20137.","journal-title":"CVIR Endovasc."},{"issue":"1","key":"3165_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42155-020-00130-5","volume":"3","author":"V Lucas Cava","year":"2020","unstructured":"Lucas Cava V, S\u00e1nchez Margallo FM, B\u00e1ez D\u00edaz C, D\u00e1vila G\u00f3mez L, Lima Rodr\u00edguez JR, Sun F. Prostatic artery embolization with polyethylene glycol microspheres: evaluation in a canine spontaneous benign prostatic hyperplasia model. CVIR Endovasc. 2020;3(1):1\u20138.","journal-title":"CVIR Endovasc."},{"issue":"4","key":"3165_CR14","first-page":"373","volume":"79","author":"World Medical Association Declaration of Helsinki","year":"2001","unstructured":"World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ. 2001;79(4):373\u20134.","journal-title":"Bull World Health Organ"},{"issue":"2","key":"3165_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/105294199277860","volume":"6","author":"JRJ Dixon","year":"1998","unstructured":"Dixon JRJ. The international conference harmonization good clinical practice guideline. Qual Assur. 1998;6(2):65\u201374.","journal-title":"Qual Assur."},{"issue":"6","key":"3165_CR16","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/EDE.0b013e3181577654","volume":"18","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology. 2007;18(6):800\u20134.","journal-title":"Epidemiology"},{"issue":"2","key":"3165_CR17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s00270-019-02379-3","volume":"43","author":"FH Cornelis","year":"2020","unstructured":"Cornelis FH, Bilhim T, Hacking N, Sapoval M, Tapping CR, Carnevale FC. CIRSE standards of practice on prostatic artery embolisation. Cardiovasc Intervent Radiol. 2020;43(2):176\u201385.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"3165_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313.","journal-title":"Ann Surg"},{"issue":"6","key":"3165_CR19","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jvir.2019.12.810","volume":"31","author":"I Insausti","year":"2020","unstructured":"Insausti I, S\u00e1ez de Oc\u00e1rizGalbete AA, Capdevila F, Solchaga S, Giral P, et al. Randomized comparison of prostatic artery embolization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia. J Vasc Interv Radiol. 2020;31(6):882\u201390.","journal-title":"J Vasc Interv Radiol."},{"key":"3165_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2338","author":"D Abt","year":"2018","unstructured":"Abt D, Hechelhammer L, M\u00fcllhaupt G, Markart S, G\u00fcsewell S, Kessler TM, et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: Randomised, open label, non-inferiority trial. BMJ. 2018. https:\/\/doi.org\/10.1136\/bmj.k2338.","journal-title":"BMJ"},{"issue":"2","key":"3165_CR21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.urology.2014.04.028","volume":"84","author":"D Kurbatov","year":"2014","unstructured":"Kurbatov D, Russo GI, Lepetukhin A, Dubsky S, Sitkin I, Morgia G, et al. Prostatic artery embolization for prostate volume greater than 80 cm3: results from a single-center prospective study. Urology. 2014;84(2):400\u20134.","journal-title":"Urology"},{"issue":"1","key":"3165_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jvir.2013.09.010","volume":"25","author":"S Bagla","year":"2014","unstructured":"Bagla S, Martin CP, van Breda A, Sheridan MJ, Sterling KM, Papadouris D, et al. Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia. J Vasc Interv Radiol. 2014;25(1):47\u201352.","journal-title":"J Vasc Interv Radiol"},{"issue":"10","key":"3165_CR23","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s00270-016-1443-x","volume":"39","author":"OM Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves OM, Carnevale FC, Moreira AM, Antunes AA, Rodrigues VC, Srougi M. Comparative study using 100\u2013300 versus 300\u2013500 \u03bcm microspheres for symptomatic patients due to enlarged-BPH prostates. Cardiovasc Intervent Radiol. 2016;39(10):1372\u20138.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"3165_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jvir.2019.08.005","volume":"31","author":"R Ayyagari","year":"2020","unstructured":"Ayyagari R, Powell T, Staib L, Chapiro J, Raja A, Bhatia S, et al. Prostatic artery embolization using 100\u2013300-\u03bcm trisacryl gelatin microspheres to treat lower urinary tract symptoms attributable to benign prostatic hyperplasia: a single-center outcomes analysis with medium-term follow-up. J Vasc Interv Radiol. 2020;31(1):99\u2013107.","journal-title":"J Vasc Interv Radiol"},{"issue":"9","key":"3165_CR25","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1007\/s00330-012-2714-9","volume":"23","author":"JM Pisco","year":"2013","unstructured":"Pisco JM, Rio Tinto H, Campos Pinheiro L, Bilhim T, Duarte M, Fernandes L, et al. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up. Eur Radiol. 2013;23(9):2561\u201372.","journal-title":"Eur Radiol"},{"issue":"2","key":"3165_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00270-015-1238-5","volume":"39","author":"F Sun","year":"2016","unstructured":"Sun F, Cris\u00f3stomo V, B\u00e1ez-D\u00edaz C, S\u00e1nchez FM. Prostatic artery embolization (PAE) for symptomatic benign prostatic hyperplasia (BPH): Part 2, insights into the technical rationale. Cardiovasc Intervent Radiol. 2016;39(2):161\u20139.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"3165_CR27","doi-asserted-by":"publisher","first-page":"S155","DOI":"10.1016\/j.jvir.2014.12.418","volume":"26","author":"NV Costa","year":"2015","unstructured":"Costa NV, Pisco JM, Bilhim T, Pinheiro L, Fernandes L, Pereira JA, et al. The safety and efficacy of prostatic arteries embolization with polyzene-coated microspheres (Embozene) for benign prostatic hyperplasia\u2014preliminary results. J Vasc Interv Radiol. 2015;26(2):S155.","journal-title":"J Vasc Interv Radiol"},{"key":"3165_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.urology.2019.11.003","volume":"136","author":"R Ayyagari","year":"2020","unstructured":"Ayyagari R, Powell T, Staib L, Chapiro J, Perez-Lozada J-C, Bhatia S, et al. Prostatic artery embolization in nonindex benign prostatic hyperplasia patients: single-center outcomes for urinary retention and gross prostatic hematuria. Urology. 2020;136:212\u20137.","journal-title":"Urology"},{"issue":"4","key":"3165_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jvir.2012.12.019","volume":"24","author":"FC Carnevale","year":"2013","unstructured":"Carnevale FC, Da Motta-Leal-Filho JM, Antunes AA, Baroni RH, Marcelino ASZ, Cerri LMO, et al. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia. J Vasc Interv Radiol. 2013;24(4):535\u201342.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"3165_CR30","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00270-017-1582-8","volume":"40","author":"A Rampoldi","year":"2017","unstructured":"Rampoldi A, Barbosa F, Secco S, Migliorisi C, Galfano A, Prestini G, et al. Prostatic artery embolization as an alternative to indwelling bladder catheterization to manage benign prostatic hyperplasia in poor surgical candidates. Cardiovasc Intervent Radiol. 2017;40(4):530\u20136.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"3165_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jvir.2017.08.022","volume":"29","author":"S Bhatia","year":"2018","unstructured":"Bhatia S, Sinha VK, Kava BR, Gomez C, Harward S, Punnen S, et al. Efficacy of prostatic artery embolization for catheter-dependent patients with large prostate sizes and high comorbidity scores. J Vasc Interv Radiol. 2018;29(1):78-84.e1.","journal-title":"J Vasc Interv Radiol"},{"issue":"11","key":"3165_CR32","doi-asserted-by":"publisher","first-page":"e786","DOI":"10.1016\/j.amjmed.2019.04.037","volume":"132","author":"AG Kenny","year":"2019","unstructured":"Kenny AG, Pellerin O, Amouyal G, Desgranchamps F, M\u00e9ria P, De Gouvello A, et al. Prostate artery embolization in patients with acute urinary retention. Am J Med. 2019;132(11):e786\u201390.","journal-title":"Am J Med"},{"issue":"4","key":"3165_CR33","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1007\/s00270-013-0611-5","volume":"36","author":"AA Antunes","year":"2013","unstructured":"Antunes AA, Carnevale FC, Da Motta Leal Filho JM, Yoshinaga EM, Cerri LMO, Baroni RH, et al. Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. a prospective single-center pilot study. Cardiovasc Intervent Radiol. 2013;36(4):978\u201386.","journal-title":"Cardiovasc Intervent Radiol."},{"issue":"1","key":"3165_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00270-015-1202-4","volume":"39","author":"FC Carnevale","year":"2016","unstructured":"Carnevale FC, Iscaife A, Yoshinaga EM, Moreira AM, Antunes AA, Srougi M. Transurethral resection of the prostate (TURP) versus original and PErFecTED prostate artery embolization (PAE) due to benign prostatic hyperplasia (BPH): preliminary results of a single center, prospective. Urodyn-Controlled Anal Cardiovasc Intervent Radiol. 2016;39(1):44\u201352.","journal-title":"Urodyn-Controlled Anal Cardiovasc Intervent Radiol"},{"issue":"5","key":"3165_CR35","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s00270-018-02156-8","volume":"42","author":"N Hacking","year":"2019","unstructured":"Hacking N, Vigneswaran G, Maclean D, Modi S, Dyer J, Harris M, et al. Technical and imaging outcomes from the UK registry of prostate artery embolization (UK-ROPE) study: focusing on predictors of clinical success. Cardiovasc Intervent Radiol. 2019;42(5):666\u201376.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"8","key":"3165_CR36","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.jvir.2016.04.001","volume":"27","author":"JM Pisco","year":"2016","unstructured":"Pisco JM, Bilhim T, Pinheiro LC, Fernandes L, Pereira J, Costa NV, et al. Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients. J Vasc Interv Radiol. 2016;27(8):1115\u201322.","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"3165_CR37","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.eururo.2019.11.010","volume":"77","author":"JM Pisco","year":"2020","unstructured":"Pisco JM, Bilhim T, Costa NV, Torres D, Pisco J, Pinheiro LC, et al. Randomised clinical trial of prostatic artery embolisation versus a sham procedure for benign prostatic hyperplasia. Eur Urol. 2020;77(3):354\u201362.","journal-title":"Eur Urol"},{"issue":"8","key":"3165_CR38","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1007\/s00270-020-02520-7","volume":"43","author":"L Marzano","year":"2020","unstructured":"Marzano L, Thiounn N, Pereira H, Pellerin O, Dariane C, Del Giudice C, et al. Prostatic artery embolization allows to maintain full sexual activity in patients suffering from bothersome lower urinary tracts symptoms related to benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2020;43(8):1202\u20137.","journal-title":"Cardiovasc Intervent Radiol"}],"updated-by":[{"DOI":"10.1007\/s00270-023-03371-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000}}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-022-03165-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-022-03165-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-022-03165-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T07:06:46Z","timestamp":1674630406000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-022-03165-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["3165"],"URL":"https:\/\/doi.org\/10.1007\/s00270-022-03165-4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00270-023-03371-8","asserted-by":"object"}]},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"assertion":[{"value":"27 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00270-023-03371-8","URL":"https:\/\/doi.org\/10.1007\/s00270-023-03371-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}